Inspiration Hlt Regulatory News (IHC)

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Launch of the CosyTherm2

and

Mello Investor Conference

Inspiration Healthcare (AIM:IHC), the global medical technology company, today announces the launch of the CosyTherm2 neonatal controller to accompany various neonatal mattresses. The launch of the CosyTherm2 follows the successful launch of its patient warming system incorporating the AlphaCore5 controller in 2018.

The CosyTherm2 has been specifically designed for the neonatal market, using pastel colouring to blend in with the nursery surroundings of neonatal intensive care and transitional care units. The CosyTherm2, unlike the AlphaCore5 model, has only 2 accessory outlets making it more suitable for the neonatal environment. As part as its on-going product development programme, the company plans to bring out further mattresses for the patient warming system over the coming months.

The new CosyTherm2 neonatal controller and warming mattresses will be introduced to a wide range of distributors from all over the world at Medica, the world's largest medical trade fair for medical technology in November. The Company has had encouraging responses from its international distribution partners, with the first orders now received.

Mello London, 2019

Inspiration Healthcare is participating in the Mello London, 2019 investor conference which takes place between Tuesday 12 and Wednesday 13 November 2019 at the Clayton Hotel Chiswick, Chiswick High Road, London, W4 5RY. Neil Campbell, CEO of Inspiration Healthcare, will be presenting to delegates on Tuesday 12 November 2019 at 10.00am and 12.30pm.

Enquiries:

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies. 

Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally the Company has its own range of products for maintaining normothermia pre- during and post-surgery.

With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com